IDEAYA Biosciences (IDYA) Gains from Sales and Divestitures (2019 - 2021)
IDEAYA Biosciences' (IDYA) quarterly Gains from Sales and Divestitures came in at $7312.0 in Q4 2021, little changed quarter-over-quarter from $7312.0 in Q3 2021.
IDEAYA Biosciences (IDYA) Gains from Sales and Divestitures (2019 - 2021) Analysis & Trends
IDEAYA Biosciences has disclosed Gains from Sales and Divestitures across 2 years of filings, most recently posting $7312.0 for Q4 2021.
- Gains from Sales and Divestitures for Q4 2021 came in at $7312.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2021 was $7312.0 (changed N/A YoY), and the FY2021 annual result was $7312.0, changed N/A from the prior year.
- Gains from Sales and Divestitures came in at $7312.0 for Q4 2021 at IDEAYA Biosciences, roughly flat from $7312.0 in the prior quarter.
- In the past five years, Gains from Sales and Divestitures ranged from a high of $7312.0 in Q1 2021 to a low of $4099.0 in Q2 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | IDEAYA Biosciences | 2.78 Bn | 2.10 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 7,312.00 |
| Dec 31, 2021 | 7,312.00 |
| Sep 30, 2021 | 7,312.00 |
| Sep 30, 2021 | 7,312.00 |
| Jun 30, 2021 | 7,312.00 |
| Jun 30, 2021 | 7,312.00 |
| Mar 31, 2021 | 7,312.00 |
| Mar 31, 2021 | 7,312.00 |
| Dec 31, 2019 | 4,867.00 |
| Dec 31, 2019 | 4,867.00 |
| Sep 30, 2019 | 4,593.00 |
| Sep 30, 2019 | 4,593.00 |
| Jun 30, 2019 | 4,099.00 |
| Jun 30, 2019 | 4,099.00 |